SHR-3045 Placebo Injection

DRUG2 trials

Sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd

Conditions

Rheumatoid ArthritisRheumatoid Arthritis (RA)

Phase 1

A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects

CompletedNCT06883695

Guangdong Hengrui Pharmaceutical Co., LtdRheumatoid Arthritis

Start: 2025-04-08End: 2025-10-10Updated: 2026-06-05

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

CompletedNCT07200596

Guangdong Hengrui Pharmaceutical Co., LtdRheumatoid Arthritis (RA)

Start: 2025-10-08End: 2026-03-31Updated: 2026-06-11